Pharmaceutical Companies Bid for Northern Botanical Garden Collections in Attempt to Avoid the Biodiversity Convention

Cotton "Failing in the Field"

Pharmaceutical firms and biotech companies are approaching botanical gardens to buy samples of tropical plant diversity - a clear violation of the spirit - if not the law - of the Convention on Biological Diversity. The rights of farmers and indigenous peoples are being bypassed by corporate deals that make a mockery of the CBD's fundamental principles.

AttachmentSize
PDF icon Download File0 bytes

Please consider supporting ETC's unique research and advocacy with a tax-deductibe donation. Donate here